{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T09:15:30Z","timestamp":1794734130125,"version":"4.9.1"},"reference-count":52,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","clinical-genitourinary-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Genitourinary Cancer"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.clgc.2024.102077","type":"journal-article","created":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T22:30:59Z","timestamp":1710455459000},"page":"102077","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Adrenocortical Cancer in the Real World: A Comprehensive Analysis of Clinical Features and Management from the Turkish Oncology Group (TOG)"],"prefix":"10.1016","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0545-1383","authenticated-orcid":false,"given":"Hatime Arzu","family":"Yasar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burak Yasin","family":"Aktas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7649-1075","authenticated-orcid":false,"given":"Gokhan","family":"Ucar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sema Sezgin","family":"Goksu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irem","family":"Bilgetekin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burcu","family":"Cakar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah","family":"Sakin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozturk","family":"Ates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tugba","family":"Basoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cagatay","family":"Arslan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atike Gokcen","family":"Demiray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Semra","family":"Paydas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irfan","family":"Cicin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7021-6139","authenticated-orcid":false,"given":"Mehmet Ali Nahit","family":"Sendur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuri","family":"Karadurmus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hakan","family":"Kosku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aytu\u011f","family":"Uner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8650-299X","authenticated-orcid":false,"given":"Perran Fulden","family":"Yumuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gungor","family":"Utkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umut","family":"Kefeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozgur","family":"Tanriverdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Havva","family":"Cinkir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozge","family":"Gumusay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1013-5676","authenticated-orcid":false,"given":"Naz\u0131m Serdal","family":"Turhal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serkan","family":"Menekse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Engin","family":"Kut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0853-4096","authenticated-orcid":false,"given":"Ismail","family":"Beypinar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teoman","family":"Sakalar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hacer","family":"Demir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emre","family":"Yekeduz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saadettin","family":"Kilickap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Erman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9152-9887","authenticated-orcid":false,"given":"Yuksel","family":"Urun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.clgc.2024.102077_bib0001","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1210\/jc.2005-2639","article-title":"Clinical review: adrenocortical carcinoma: clinical update","volume":"91","author":"Allolio","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.clgc.2024.102077_bib0002","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1210\/jc.2005-2730","article-title":"Clinical and biological features in the prognosis of adrenocortical cancer: poor outcome of cortisol-secreting tumors in a series of 202 consecutive patients","volume":"91","author":"Abiven","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.clgc.2024.102077_bib0003","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1002\/cncr.23886","article-title":"Adrenocortical carcinoma in the United States: treatment utilization and prognostic factors","volume":"113","author":"Bilimoria","year":"2008","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.clgc.2024.102077_bib0004","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-18-0608","article-title":"European Society of Endocrinology Clinical Practice guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors","volume":"179","author":"Fassnacht","year":"2018","journal-title":"Eur J Endocrinol"},{"issue":"Suppl 7","key":"10.1016\/j.clgc.2024.102077_bib0005","article-title":"Adrenal cancer: ESMO Clinical Practice guidelines for diagnosis, treatment and follow-up","volume":"23","author":"Berruti","year":"2012","journal-title":"Ann Oncol"},{"issue":"1-2","key":"10.1016\/j.clgc.2024.102077_bib0006","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.mce.2013.10.028","article-title":"Genetics and epigenetics of adrenocortical tumors","volume":"386","author":"Lerario","year":"2014","journal-title":"Mol Cell Endocrinol"},{"issue":"3","key":"10.1016\/j.clgc.2024.102077_bib0007","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1530\/EJE-11-0918","article-title":"Phase II study of weekly paclitaxel and sorafenib as second\/third-line therapy in patients with adrenocortical carcinoma","volume":"166","author":"Berruti","year":"2012","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"10.1016\/j.clgc.2024.102077_bib0008","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1210\/jc.2013-2298","article-title":"The VEGF inhibitor axitinib has limited effectiveness as a therapy for adrenocortical cancer","volume":"99","author":"O'Sullivan","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.clgc.2024.102077_bib0009","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1210\/jc.2007-2564","article-title":"Treatment of advanced adrenocortical carcinoma with erlotinib plus gemcitabine","volume":"93","author":"Quinkler","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.clgc.2024.102077_bib0010","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/MED.0000000000000332","article-title":"Update on adrenocortical carcinoma management and future directions","volume":"24","author":"Varghese","year":"2017","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"9","key":"10.1016\/j.clgc.2024.102077_bib0011","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers12092720","article-title":"Development and internal validation of a multivariable prediction model for adrenocortical-carcinoma-specific mortality","volume":"12","author":"Ettaieb","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.clgc.2024.102077_bib0012","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.humpath.2016.09.035","article-title":"Validation of the prognostic role of the \u201cHelsinki Score\u201d in 225 cases of adrenocortical carcinoma","volume":"62","author":"Duregon","year":"2017","journal-title":"Hum Pathol"},{"issue":"11","key":"10.1016\/j.clgc.2024.102077_bib0013","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1055\/a-1666-9026","article-title":"Adrenocortical cancer: a 20-year experience of a single referral center in prognosis and outcomes","volume":"53","author":"Parianos","year":"2021","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.clgc.2024.102077_bib0014","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.952418","article-title":"Prognostic factors and mitotane treatment of adrenocortical cancer. Two decades of experience from an institutional case series","volume":"13","author":"Toke","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"10","key":"10.1016\/j.clgc.2024.102077_bib0015","first-page":"2817","article-title":"Prognostic factors of adrenocortical carcinoma: an analysis of the surveillance epidemiology and end results (SEER) database","volume":"18","author":"Wang","year":"2017","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.clgc.2024.102077_bib0016","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.lungcan.2017.07.024","article-title":"Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab","volume":"111","author":"Diem","year":"2017","journal-title":"Lung Cancer"},{"issue":"5","key":"10.1016\/j.clgc.2024.102077_bib0017","doi-asserted-by":"crossref","first-page":"467","DOI":"10.56434\/j.arch.esp.urol.20227505.68","article-title":"The clinicopathological and prognostic value of NLR, PLR and MLR in non-muscular invasive bladder cancer","volume":"75","author":"Chen","year":"2022","journal-title":"Arch Esp Urol"},{"key":"10.1016\/j.clgc.2024.102077_bib0018","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/7971415","article-title":"Value research of NLR, PLR, and RDW in prognostic assessment of patients with colorectal cancer","volume":"2022","author":"Chen","year":"2022","journal-title":"J Healthc Eng"},{"issue":"7","key":"10.1016\/j.clgc.2024.102077_bib0019","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1177\/1078155219900908","article-title":"Neutrophil-lymphocyte ratio as a prognostic factor for survival in patients with advanced renal cell carcinoma (Turkish Oncology Group Study)","volume":"26","author":"Hizal","year":"2020","journal-title":"J Oncol Pharm Pract"},{"issue":"9","key":"10.1016\/j.clgc.2024.102077_bib0020","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.3748\/wjg.v21.i9.2807","article-title":"Prognostic significance of neutrophil to lymphocyte ratio in pancreatic cancer: a meta-analysis","volume":"21","author":"Yang","year":"2015","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10.1016\/j.clgc.2024.102077_bib0021","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.beem.2008.10.008","article-title":"Clinical management of adrenocortical carcinoma","volume":"23","author":"Fassnacht","year":"2009","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.clgc.2024.102077_bib0022","doi-asserted-by":"crossref","first-page":"98","DOI":"10.5489\/cuaj.4650","article-title":"The impact of patient-, disease-, and treatment-related factors on survival in patients with adrenocortical carcinoma","volume":"12","author":"Punjani","year":"2018","journal-title":"Can Urol Assoc J"},{"issue":"6","key":"10.1016\/j.clgc.2024.102077_bib0023","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.canep.2010.04.013","article-title":"Cancer survival as a function of age at diagnosis: a study of the Surveillance, Epidemiology and End Results database","volume":"34","author":"Bassily","year":"2010","journal-title":"Cancer Epidemiol"},{"issue":"11","key":"10.1016\/j.clgc.2024.102077_bib0024","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.annonc.2020.08.2099","article-title":"Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"31","author":"Fassnacht","year":"2020","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.clgc.2024.102077_bib0025","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1210\/jc.2014-3182","article-title":"Major prognostic role of Ki67 in localized adrenocortical carcinoma after complete resection","volume":"100","author":"Beuschlein","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.clgc.2024.102077_bib0026","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.eururo.2013.11.006","article-title":"Prognostic role of overt hypercortisolism in completely operated patients with adrenocortical cancer","volume":"65","author":"Berruti","year":"2014","journal-title":"Eur Urol"},{"issue":"10","key":"10.1016\/j.clgc.2024.102077_bib0027","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1007\/s12325-019-01050-0","article-title":"prognostic role of Ki-67 in adrenocortical carcinoma after primary resection: a retrospective mono-institutional study","volume":"36","author":"Zhang","year":"2019","journal-title":"Adv Ther"},{"issue":"11","key":"10.1016\/j.clgc.2024.102077_bib0028","doi-asserted-by":"crossref","first-page":"4026","DOI":"10.1007\/s00464-013-3034-0","article-title":"Does laparoscopic adrenalectomy jeopardize oncologic outcomes for patients with adrenocortical carcinoma?","volume":"27","author":"Cooper","year":"2013","journal-title":"Surg Endosc"},{"issue":"6","key":"10.1016\/j.clgc.2024.102077_bib0029","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.surg.2018.07.026","article-title":"Laparoscopic versus open adrenalectomy for localized (stage 1\/2) adrenocortical carcinoma: experience at a single, high-volumecenter","volume":"164","author":"Wu","year":"2018","journal-title":"Surgery"},{"key":"10.1016\/j.clgc.2024.102077_bib0030","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.2147\/OTT.S157518","article-title":"Open adrenalectomy versus laparoscopic adrenalectomy for adrenocortical carcinoma: a retrospective comparative study on short-term oncologic prognosis","volume":"11","author":"Zheng","year":"2018","journal-title":"Onco Targets Ther"},{"issue":"1","key":"10.1016\/j.clgc.2024.102077_bib0031","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1089\/lap.2007.0085","article-title":"Laparoscopic adrenalectomy for adrenal malignancy: a preliminary report comparing the short-term outcomes with open adrenalectomy","volume":"18","author":"Kirshtein","year":"2008","journal-title":"J Laparoendosc Adv Surg Tech A"},{"issue":"5","key":"10.1016\/j.clgc.2024.102077_bib0032","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.eururo.2010.01.036","article-title":"Retrospective evaluation of the outcome of open versus laparoscopic adrenalectomy for stage I and II adrenocortical cancer","volume":"57","author":"Porpiglia","year":"2010","journal-title":"Eur Urol"},{"issue":"12","key":"10.1016\/j.clgc.2024.102077_bib0033","doi-asserted-by":"crossref","first-page":"4551","DOI":"10.1210\/jc.2013-3020","article-title":"Update in adrenocortical carcinoma","volume":"98","author":"Fassnacht","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.clgc.2024.102077_bib0034","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1002\/jso.26138","article-title":"Critical analysis of lymph node examination in patients undergoing curative-intent resection for adrenocortical carcinoma","volume":"122","author":"Deschner","year":"2020","journal-title":"J Surg Oncol"},{"issue":"3","key":"10.1016\/j.clgc.2024.102077_bib0035","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1245\/s10434-021-11051-5","article-title":"Adrenocortical carcinoma: the value of lymphadenectomy","volume":"29","author":"Tseng","year":"2022","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10.1016\/j.clgc.2024.102077_bib0036","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1530\/EJE-18-0450","article-title":"Influence of hormonal functional status on survival in adrenocortical carcinoma: systematic review and meta-analysis","volume":"179","author":"Vanbrabant","year":"2018","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"10.1016\/j.clgc.2024.102077_bib0037","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1210\/clinem\/dgab865","article-title":"Cytoreductive surgery of the primary tumor in metastatic adrenocortical carcinoma: impact on patients' survival","volume":"107","author":"Srougi","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.clgc.2024.102077_bib0038","doi-asserted-by":"crossref","first-page":"209","DOI":"10.4149\/neo_2019_190105N17","article-title":"Clinical presentation, treatment modalities and outcome in patients with adrenocortical carcinoma: a single center experience","volume":"67","author":"Bronswijk","year":"2020","journal-title":"Neoplasma"},{"issue":"1","key":"10.1016\/j.clgc.2024.102077_bib51","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1210\/jc.2006-0706","article-title":"Prognostic parameters of metastatic adrenocortical carcinoma","volume":"92","author":"Assie","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.clgc.2024.102077_bib0039","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1093\/annonc\/mdv329","article-title":"Prognostic factors in stage III-IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study","volume":"26","author":"Libe","year":"2015","journal-title":"Ann Oncol"},{"issue":"23","key":"10.1016\/j.clgc.2024.102077_bib0040","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1056\/NEJMoa063360","article-title":"Adjuvant mitotane treatment for adrenocortical carcinoma","volume":"356","author":"Terzolo","year":"2007","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.clgc.2024.102077_bib0041","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1245\/s10434-009-0716-x","article-title":"Recurrence of adrenal cortical carcinoma following resection: surgery alone can achieve results equal to surgery plus mitotane","volume":"17","author":"Grubbs","year":"2010","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"10.1016\/j.clgc.2024.102077_bib0042","doi-asserted-by":"crossref","first-page":"3730","DOI":"10.1210\/jc.2008-0579","article-title":"Adjuvant mitotane for adrenocortical cancer: a recurring controversy","volume":"93","author":"Huang","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"23","key":"10.1016\/j.clgc.2024.102077_bib0043","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1056\/NEJMoa1200966","article-title":"Combination chemotherapy in advanced adrenocortical carcinoma","volume":"366","author":"Fassnacht","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clgc.2024.102077_bib52","doi-asserted-by":"crossref","first-page":"106959","DOI":"10.1016\/j.ijsu.2022.106959","article-title":"Prognostic value of neutrophil-to-lymphocyte ratio in colorectal cancer liver metastasis: A meta-analysis of results from multivariate analysis","volume":"107","author":"Lin","year":"2022","journal-title":"Int J Surg"},{"issue":"3","key":"10.1016\/j.clgc.2024.102077_bib0045","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1007\/s00268-020-05868-6","article-title":"neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) as possible prognostic markers for patients undergoing resection of adrenocortical carcinoma","volume":"45","author":"de Jong","year":"2021","journal-title":"World J Surg"},{"issue":"4","key":"10.1016\/j.clgc.2024.102077_bib0044","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/ERC-22-0372","article-title":"Inflammation-based scores as predictors of treatment response in advanced adrenocortical carcinoma","volume":"30","author":"Mangone","year":"2023","journal-title":"Endocr Relat Cancer"},{"issue":"7","key":"10.1016\/j.clgc.2024.102077_bib0046","doi-asserted-by":"crossref","first-page":"bvaa069","DOI":"10.1210\/jendso\/bvaa069","article-title":"Salvage therapy with multikinase inhibitors and immunotherapy in advanced adrenal cortical carcinoma","volume":"4","author":"Miller","year":"2020","journal-title":"J Endocr Soc"},{"issue":"1","key":"10.1016\/j.clgc.2024.102077_bib0047","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2021.1908771","article-title":"Combination immunotherapy with ipilimumab and nivolumab in patients with advanced adrenocortical carcinoma: a subgroup analysis of CA209-538","volume":"10","author":"Klein","year":"2021","journal-title":"Oncoimmunology"},{"issue":"12","key":"10.1016\/j.clgc.2024.102077_bib0048","doi-asserted-by":"crossref","first-page":"6193","DOI":"10.1210\/jc.2019-00600","article-title":"Nivolumab in metastatic adrenocortical carcinoma: results of a phase 2 trial","volume":"104","author":"Carneiro","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.clgc.2024.102077_bib0049","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s40425-018-0424-9","article-title":"Avelumab in patients with previously treated metastatic adrenocortical carcinoma: phase 1b results from the JAVELIN solid tumor trial","volume":"6","author":"Le Tourneau","year":"2018","journal-title":"J Immunother Cancer"},{"issue":"1","key":"10.1016\/j.clgc.2024.102077_bib0050","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1200\/JCO.19.01586","article-title":"PD-1 blockade in advanced adrenocortical carcinoma","volume":"38","author":"Raj","year":"2020","journal-title":"J Clin Oncol"}],"container-title":["Clinical Genitourinary Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S155876732400048X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S155876732400048X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T04:01:04Z","timestamp":1717646464000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S155876732400048X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":52,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S155876732400048X"],"URL":"https:\/\/doi.org\/10.1016\/j.clgc.2024.102077","relation":{},"ISSN":["1558-7673"],"issn-type":[{"value":"1558-7673","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adrenocortical Cancer in the Real World: A Comprehensive Analysis of Clinical Features and Management from the Turkish Oncology Group (TOG)","name":"articletitle","label":"Article Title"},{"value":"Clinical Genitourinary Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clgc.2024.102077","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102077"}}